Idorsia Ltd
SIX:IDIA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Profarma Distribuidora de Produtos Farmaceuticos SA
BOVESPA:PFRM3
|
BR |
|
B
|
Bajel Projects Ltd
NSE:BAJEL
|
IN |
|
Petroleo Brasileiro SA Petrobras
BOVESPA:PETR4
|
BR |
Idorsia Ltd
Other Current Liabilities
Idorsia Ltd
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Idorsia Ltd
SIX:IDIA
|
Other Current Liabilities
CHf36.3m
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Other Current Liabilities
$14.1m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Other Current Liabilities
$30m
|
CAGR 3-Years
431%
|
CAGR 5-Years
8%
|
CAGR 10-Years
77%
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Other Current Liabilities
CHf8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-17%
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Other Current Liabilities
CHf500k
|
CAGR 3-Years
-56%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Relief Therapeutics Holding SA
SIX:RLF
|
Other Current Liabilities
CHf2.8m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
Glance View
Idorsia Ltd. operates as a biopharmaceutical firm which focuses on discovery, development and commercialization of innovative medicines for unmet medical needs. The company is headquartered in Allschwil, Basel-Landschaft. The company went IPO on 2017-06-16. The firm will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The firm's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.
See Also
What is Idorsia Ltd's Other Current Liabilities?
Other Current Liabilities
36.3m
CHF
Based on the financial report for Dec 31, 2025, Idorsia Ltd's Other Current Liabilities amounts to 36.3m CHF.
What is Idorsia Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 3Y
48%
Over the last year, the Other Current Liabilities growth was -39%. The average annual Other Current Liabilities growth rates for Idorsia Ltd have been 48% over the past three years .
